Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Consensus Rating of "Moderate Buy" by Brokerages

Key Points

• Aveanna Healthcare Holdings Inc. has been given a consensus rating of "Moderate Buy" from five brokerages, with an average 1-year price target of $7.50.
• Several analysts have upgraded Aveanna Healthcare's ratings recently, with notable increases in price targets from UBS Group and Barclays.
• Institutional investors hold 87.96% of Aveanna Healthcare's stock, indicating significant interest and confidence in the company's prospects.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) has received a consensus rating of "Moderate Buy" from the five brokerages that are covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price objective among brokers that have covered the stock in the last year is $7.50.

Several research analysts have recently weighed in on the company. UBS Group raised Aveanna Healthcare from a "sell" rating to a "neutral" rating and lifted their price objective for the stock from $6.75 to $8.00 in a research report on Tuesday, August 19th. Barclays raised Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and lifted their price objective for the stock from $5.50 to $9.50 in a research report on Tuesday, August 19th. Jefferies Financial Group raised Aveanna Healthcare from a "hold" rating to a "buy" rating and decreased their target price for the company from $6.25 to $6.00 in a research report on Monday, July 21st. Wall Street Zen raised Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 9th. Finally, Raymond James Financial raised Aveanna Healthcare from a "market perform" rating to an "outperform" rating and set a $9.00 target price for the company in a research report on Monday, August 11th.

Aveanna Healthcare Trading Up 0.2%

AVAH stock opened at $8.44 on Monday. The stock has a 50-day moving average price of $5.94 and a 200-day moving average price of $5.32. Aveanna Healthcare has a 1-year low of $3.67 and a 1-year high of $8.54. The firm has a market cap of $1.76 billion, a PE ratio of 105.50 and a beta of 2.03.

Institutional Trading of Aveanna Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Banque Transatlantique SA bought a new stake in Aveanna Healthcare in the 1st quarter valued at about $25,000. BNP Paribas Financial Markets bought a new stake in Aveanna Healthcare during the 4th quarter worth approximately $35,000. Quantbot Technologies LP bought a new stake in Aveanna Healthcare during the 2nd quarter worth approximately $43,000. Diversified Trust Co bought a new stake in Aveanna Healthcare during the 2nd quarter worth approximately $57,000. Finally, Jump Financial LLC bought a new stake in Aveanna Healthcare during the 1st quarter worth approximately $59,000. 87.96% of the stock is owned by institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.